Trial Profile
A Phase 2, Multi-Center, Open Label, Simon Two-Stage Study to Evaluate the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2022
Price :
$35
*
At a glance
- Drugs Fostamatinib (Primary)
- Indications Autoimmune haemolytic anaemia
- Focus Proof of concept; Therapeutic Use
- Acronyms SOAR
- Sponsors Rigel Pharmaceuticals
- 01 Jun 2022 Results published in the American Journal of Hematology
- 08 Mar 2022 According to Rigel Pharmaceuticals media release, results from this trial presented at American Journal of Hematology
- 08 Mar 2022 Results published in the Rigel Pharmaceuticals Media Release